interleukin-1 receptor gene therapy (Theragen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterleukin-1 receptor gene therapy (Theragen)
Drug Alias NameIL-1 receptor gene therapy (Theragen)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-1 receptor modulators
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheragen IncWarner Lambert
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A